SP326COMPARING THE EFFICACY OF CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR AND DARBEPOETIN ALFA TREATMENTS IN JAPANESE PATIENTS WITH CHRONIC KIDNEY DISEASE DURING THE PREDIALYSIS PERIOD: A PROPENSITY-MATCHED ANALYSIS
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.